MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$37,515K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of marketable securit...
Accounts payable and accrued lia...
Provision for credit losses and ...
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Accounts receivable
Prepaid expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-381
-13,933
5,579
-50,130
Depreciation and amortization
5,222
5,042
5,254
5,173
Stock-based compensation
20,039
21,491
21,106
21,006
Amortization of premium and accretion of discounts, net
782
730
962
892
Amortization of operating lease right-of-use assets
1,530
1,503
1,473
1,448
Amortization of debt discount
786
809
750
746
Change in fair value of strategic investments
822
1,447
1,822
894
Provision for credit losses and contractual allowances
29,576
27,844
19,505
25,457
Acquired in-process research and development
299
296
740
302
Loss on extinguishment of debt
-
-
0
0
Impairment charges
0
-
1,979
0
Other
-152
340
5
790
Accounts receivable
32,988
33,000
19,054
19,461
Inventory
-1,174
2,424
2,062
1,849
Prepaid expenses and other current assets
31,120
4,613
2,563
1,276
Other assets
3,513
1,981
-531
3,708
Accounts payable and accrued liabilities
64,782
-22,522
-1,645
15,007
Deferred revenue
149
-145
-23
725
Operating lease liabilities
-2,719
-2,703
-2,579
-2,479
Net cash provided by operating activities
51,080
-26,173
26,212
34,883
Purchases of property and equipment
13,565
6,905
11,723
14,831
Purchases of marketable securities
160,423
94,030
125,575
171,073
Maturities of marketable securities
125,850
132,650
88,500
99,000
Purchases of strategic investments
500
1,500
0
2,300
Purchase of acquired in-process research and development
-
-
0
0
Net cash used in investing activities
-48,638
30,215
-48,798
-89,204
Payment of term loan/debt and termination costs-Silicon Valley Bank Term Loan
-
-
0
0
Proceeds from term loan/debt-Braidwell Term Loan Facility
-
-
0
0
Payment of issuance costs for long-term debt-Braidwell Term Loan Facility
-
-
0
0
Payment of term loan/debt and termination costs-Braidwell Term Loan Facility
-
-
0
0
Proceeds from issuance of 2029 notes-Convertible Notes Due2029
-
-
-
0
Proceeds from issuance of 2029 notes
-
-
0
-
Payment of issuance costs for long-term debt-Convertible Notes Due2029
-
-
0
0
Purchases of capped call transactions
-
-
0
0
Purchase of treasury stock
-
-
0
0
Proceeds from issuance of common stock in connection with employee equity incentive plans
4,083
149
2,959
825
Repayment of 2029 notes
3
-
-
-
Net cash provided by financing activities
4,080
149
2,959
825
Effect of exchange rate changes
11
-57
34
-4
Net increase (decrease) in cash, cash equivalents and restricted cash
6,533
4,134
-19,593
-53,500
Cash, cash equivalents and restricted cash, beginning of period
263,963
263,963
-
427,955
Cash, cash equivalents and restricted cash, end of period
255,037
-
-
-
Cash and cash equivalents
246,679
-
-
-
Restricted cash
8,358
-
-
-
Total cash, cash equivalents and restricted cash
255,037
248,504
-
263,963
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accounts payable and
accrued liabilities
$64,782K
(341.23%↑ Y/Y)
Proceeds from issuance of
common stock in...
$4,083K
(-53.72%↓ Y/Y)
Provision for credit
losses and contractual...
$29,576K
(-45.93%↓ Y/Y)
Stock-based compensation
$20,039K
(-56.60%↓ Y/Y)
Depreciation and
amortization
$5,222K
(-49.37%↓ Y/Y)
Amortization of operating
lease right-of-use...
$1,530K
(-45.67%↓ Y/Y)
Inventory
-$1,174K
(-125.52%↓ Y/Y)
Amortization of debt discount
$786K
(-49.74%↓ Y/Y)
Acquired in-process
research and development
$299K
(-85.01%↓ Y/Y)
Deferred revenue
$149K
(-73.72%↓ Y/Y)
Net cash provided by
operating activities
$51,080K
(158.40%↑ Y/Y)
Net cash provided by
financing activities
$4,080K
(-53.76%↓ Y/Y)
Effect of exchange rate
changes
$11K
(137.93%↑ Y/Y)
Canceled cashflow
$72,477K
Canceled cashflow
$3K
Net increase
(decrease) in cash, cash...
$6,533K
(105.91%↑ Y/Y)
Canceled cashflow
$48,638K
Accounts receivable
$32,988K
(-42.04%↓ Y/Y)
Prepaid expenses and
other current assets
$31,120K
(1919.47%↑ Y/Y)
Other assets
$3,513K
(1341.34%↑ Y/Y)
Operating lease
liabilities
-$2,719K
(27.20%↑ Y/Y)
Change in fair value of
strategic investments
$822K
(-72.55%↓ Y/Y)
Amortization of premium and
accretion of discounts,...
$782K
(-38.57%↓ Y/Y)
Net loss
-$381K
(99.15%↑ Y/Y)
Other
-$152K
(-188.37%↓ Y/Y)
Maturities of marketable
securities
$125,850K
(150.70%↑ Y/Y)
Repayment of 2029 notes
$3K
Net cash used in
investing activities
-$48,638K
(65.02%↑ Y/Y)
Canceled cashflow
$125,850K
Purchases of marketable
securities
$160,423K
(-5.34%↓ Y/Y)
Purchases of property and
equipment
$13,565K
(-31.45%↓ Y/Y)
Purchases of strategic
investments
$500K
Buy us a coffee
iRhythm Holdings, Inc. (IRTC)
iRhythm Holdings, Inc. (IRTC)